NEMAURA MED INC's ticker is NMRD and the CUSIP is 640442208. A total of 31 filers reported holding NEMAURA MED INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $39,905 | -67.0% | 126,682 | -3.2% | 0.00% | – |
| Q2 2023 | $121,060 | +3.4% | 130,861 | 0.0% | 0.00% | – |
| Q1 2023 | $117,120 | -47.9% | 130,861 | 0.0% | 0.00% | – |
| Q4 2022 | $224,702 | -17.4% | 130,861 | +0.2% | 0.00% | – |
| Q3 2022 | $272,000 | -19.0% | 130,576 | 0.0% | 0.00% | – |
| Q2 2022 | $336,000 | -41.1% | 130,576 | 0.0% | 0.00% | – |
| Q1 2022 | $570,000 | -5.6% | 130,576 | -1.5% | 0.00% | – |
| Q4 2021 | $604,000 | -24.5% | 132,511 | -0.4% | 0.00% | – |
| Q3 2021 | $800,000 | -41.6% | 133,059 | +0.6% | 0.00% | – |
| Q2 2021 | $1,369,000 | +12.7% | 132,252 | -16.8% | 0.00% | – |
| Q1 2021 | $1,215,000 | +121.3% | 158,981 | +9.4% | 0.00% | – |
| Q4 2020 | $549,000 | +8.7% | 145,345 | +2.1% | 0.00% | – |
| Q3 2020 | $505,000 | -67.0% | 142,359 | -14.0% | 0.00% | – |
| Q2 2020 | $1,531,000 | – | 165,509 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alyeska Investment Group, L.P. | 1,842,565 | $580,408 | 0.00% |
| VANGUARD GROUP INC | 126,682 | $39,905 | 0.00% |
| UBS Group AG | 85 | $27 | 0.00% |
| NewEdge Advisors, LLC | 360 | $113 | 0.00% |
| OSAIC HOLDINGS, INC. | 500 | $158 | 0.00% |
| HAZLETT, BURT & WATSON, INC. | 30 | $0 | 0.00% |
| WELLS FARGO & COMPANY/MN | 4,158 | $1,310 | 0.00% |
| NORTHERN TRUST CORP | 26,737 | $8,422 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 107,897 | $34,829 | 0.00% |